anthranilic acid has been researched along with Leukemia in 5 studies
anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565
anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Excerpt | Relevance | Reference |
|---|---|---|
| " A driver of fibrosis is the kynurenine (Kyn) pathway, and Kyn metabolism patterns and cytokines may influence cGVHD severity and manifestation (fibrosing versus gastrointestinal [GI] cGVHD)." | 8.02 | Kynurenine pathway activation and deviation to anthranilic and kynurenic acid in fibrosing chronic graft-versus-host disease. ( Di Pasquale, P; Dischinger, K; Dreger, P; Luft, T; Monteagudo, E; Müller-Tidow, C; Orsatti, L; Radujkovic, A; Speziale, R; Stiehl, T, 2021) |
| " A driver of fibrosis is the kynurenine (Kyn) pathway, and Kyn metabolism patterns and cytokines may influence cGVHD severity and manifestation (fibrosing versus gastrointestinal [GI] cGVHD)." | 4.02 | Kynurenine pathway activation and deviation to anthranilic and kynurenic acid in fibrosing chronic graft-versus-host disease. ( Di Pasquale, P; Dischinger, K; Dreger, P; Luft, T; Monteagudo, E; Müller-Tidow, C; Orsatti, L; Radujkovic, A; Speziale, R; Stiehl, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orsatti, L | 1 |
| Stiehl, T | 1 |
| Dischinger, K | 1 |
| Speziale, R | 1 |
| Di Pasquale, P | 1 |
| Monteagudo, E | 1 |
| Müller-Tidow, C | 1 |
| Radujkovic, A | 1 |
| Dreger, P | 1 |
| Luft, T | 1 |
| EHRHART, H | 1 |
| GEORGII, A | 1 |
| STANISLAWSKI, K | 1 |
| BUDILLON, G | 1 |
| ALIFANO, A | 1 |
| GADALETA, MN | 1 |
| COLTORTI, M | 1 |
| CREPALDI, G | 1 |
| PARPAJOLA, A | 1 |
| IVANOVA, VD | 1 |
5 other studies available for anthranilic acid and Leukemia
| Article | Year |
|---|---|
Kynurenine pathway activation and deviation to anthranilic and kynurenic acid in fibrosing chronic graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Chemokine CXCL9; Female; Fibrosis; Gene Expression Regulation; Graft vs Hos | 2021 |
[Research on experimental leukemia. VI. On transplantation of leukemia following indole and 3-hydroxy-anthranilic acid in mice].
Topics: Animals; Indoles; Leukemia; Leukemia, Experimental; Leukemia, Myeloid; Mice; ortho-Aminobenzoates | 1960 |
[Tryptophan conversion to nicotinic acid in mice with Friend's leukemia. I. 3-Hydroxyanthranilic acid oxidase activity].
Topics: Animals; Friends; Leukemia; Leukemia, Experimental; Mice; Niacin; Nicotinic Acids; ortho-Aminobenzoa | 1962 |
EXCRETION OF TRYPTOPHAN METABOLITES IN DIFFERENT FORMS OF HAEMOBLASTOSIS.
Topics: Cortisone; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Kynurenic Acid; Ky | 1964 |
DISORDERS OF TRYPTOPHAN METABOLISM IN LEUKAEMIA.
Topics: Amino Acids; Child; Humans; Indoles; Kynurenine; Leukemia; ortho-Aminobenzoates; Tryptophan | 1964 |